Form 4 Filing for Context Therapeutics Inc.

This filing details a Form 4 submission for Context Therapeutics Inc. (CNTX) on June 24, 2026. Karen L. Smith, a director, was granted 45,000 stock options with a purchase price of $0.576 per share. These options vest on the earlier of June 24, 2027, or the Issuer's 2027 annual meeting of stockholders, contingent upon continued service. The options are exercisable until their expiration on June 23, 2036. This transaction is reported as acquired (code A) with a post-transaction ownership of 45,000 shares.